Plasma Exchange (TPE) — Systemic Proteome Reset
Therapeutic plasma exchange (TPE) is a clinical procedure that removes a portion of a patient's blood plasma and replaces it with a substitute fluid, typically saline and human albumin. In the context of longevity, TPE is being investigated as a method to dilute age-elevated systemic factors and pro-inflammatory proteins, potentially rejuvenating multiple tissue types and reducing biological age.
Mechanism of Action
The primary mechanism of TPE in longevity is the dilution of the aged systemic milieu. By removing old plasma, TPE acutely lowers the concentration of circulating pro-aging factors, such as elevated cytokines, senescent-associated secretory phenotype (SASP) proteins, and autoantibodies. This dilution is thought to abrogate the inhibitory effects of old serum on progenitor cell proliferation, thereby restoring tissue regenerative capacity. Furthermore, replacing plasma with 5% human albumin may provide additional antioxidant and immunomodulatory benefits, resetting the systemic proteome toward a more youthful state.
Human Trial Evidence
Recent clinical trials suggest TPE can reduce biological age markers in humans. A 2022 study by Kiprov, Conboy, and colleagues demonstrated that rounds of TPE reduced epigenetic and biological age in older adults, alongside improvements in immune cell profiles. While these early results are promising, large-scale, long-term randomized controlled trials are still needed to confirm its efficacy for systemic rejuvenation and lifespan extension.
Dosing Protocol
In longevity protocols, TPE typically involves replacing 1 to 1.5 plasma volumes with a mixture of 5% human albumin and saline. A common regimen includes a series of 3 to 6 sessions spaced over several weeks or months, depending on the specific clinical trial or practitioner protocol. The procedure requires specialized apheresis equipment and must be performed under medical supervision.
Safety & Contraindications
TPE is generally considered safe when performed by experienced clinicians, but it carries risks inherent to apheresis procedures. Adverse effects can include hypotension, hypocalcemia (due to citrate anticoagulants), allergic reactions to replacement fluids, and infection at the venous access site. It is contraindicated in individuals with severe hemodynamic instability or certain bleeding disorders.